A detailed history of Financial Advisory Service, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Financial Advisory Service, Inc. holds 7,447 shares of BMY stock, worth $433,638. This represents 0.03% of its overall portfolio holdings.

Number of Shares
7,447
Previous 7,373 1.0%
Holding current value
$433,638
Previous $306,000 25.82%
% of portfolio
0.03%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$39.66 - $51.75 $2,934 - $3,829
74 Added 1.0%
7,447 $385,000
Q2 2024

Jul 29, 2024

SELL
$40.25 - $52.99 $13,363 - $17,592
-332 Reduced 4.31%
7,373 $306,000
Q1 2024

Apr 29, 2024

SELL
$47.98 - $54.4 $13,674 - $15,504
-285 Reduced 3.57%
7,705 $417,000
Q4 2023

Jan 23, 2024

SELL
$48.48 - $57.85 $54,297 - $64,792
-1,120 Reduced 12.29%
7,990 $409,000
Q3 2023

Oct 23, 2023

SELL
$57.89 - $64.73 $17,888 - $20,001
-309 Reduced 3.28%
9,110 $528,000
Q2 2023

Aug 08, 2023

SELL
$63.71 - $70.74 $113,531 - $126,058
-1,782 Reduced 15.91%
9,419 $602,000
Q1 2023

May 11, 2023

BUY
$65.71 - $74.53 $40,937 - $46,432
623 Added 5.89%
11,201 $776,000
Q4 2022

Feb 01, 2023

SELL
$68.48 - $81.09 $46,908 - $55,546
-685 Reduced 6.08%
10,578 $760,000
Q3 2022

Oct 20, 2022

BUY
$0.13 - $76.84 $82 - $48,486
631 Added 5.93%
11,263 $801,000
Q2 2022

Aug 02, 2022

BUY
$72.62 - $79.98 $210,380 - $231,702
2,897 Added 37.45%
10,632 $819,000
Q1 2022

May 04, 2022

BUY
$61.48 - $73.72 $15,247 - $18,282
248 Added 3.31%
7,735 $565,000
Q4 2021

Feb 11, 2022

SELL
$53.63 - $62.52 $15,499 - $18,068
-289 Reduced 3.72%
7,487 $467,000
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $205,319 - $240,505
-3,470 Reduced 30.86%
7,776 $460,000
Q2 2021

Jul 29, 2021

SELL
$61.91 - $67.42 $21,297 - $23,192
-344 Reduced 2.97%
11,246 $751,000
Q1 2021

May 17, 2021

SELL
$59.34 - $66.74 $8,782 - $9,877
-148 Reduced 1.26%
11,590 $732,000
Q4 2020

Feb 10, 2021

BUY
$57.74 - $65.43 $3,868 - $4,383
67 Added 0.57%
11,738 $728,000
Q3 2020

Nov 16, 2020

BUY
$57.43 - $63.64 $40,890 - $45,311
712 Added 6.5%
11,671 $704,000
Q2 2020

Jul 21, 2020

BUY
$54.82 - $64.09 $10,799 - $12,625
197 Added 1.83%
10,959 $644,000
Q1 2020

May 14, 2020

BUY
$46.4 - $67.43 $26,633 - $38,704
574 Added 5.63%
10,762 $600,000
Q4 2019

Jan 31, 2020

BUY
$49.21 - $64.19 $32,872 - $42,878
668 Added 7.02%
10,188 $654,000
Q3 2019

Nov 06, 2019

BUY
$42.77 - $50.71 $2,993 - $3,549
70 Added 0.74%
9,520 $483,000
Q2 2019

Jul 25, 2019

BUY
$44.62 - $49.34 $2,989 - $3,305
67 Added 0.71%
9,450 $429,000
Q1 2019

May 13, 2019

BUY
$45.12 - $53.8 $5,188 - $6,187
115 Added 1.24%
9,383 $448,000
Q4 2018

Feb 08, 2019

SELL
$48.76 - $63.23 $26,427 - $34,270
-542 Reduced 5.52%
9,268 $482,000
Q3 2018

Nov 05, 2018

BUY
$55.19 - $62.25 $2,814 - $3,174
51 Added 0.52%
9,810 $609,000
Q2 2018

Jul 26, 2018

BUY
$50.53 - $62.98 $2,829 - $3,526
56 Added 0.58%
9,759 $540,000
Q1 2018

May 02, 2018

BUY
$59.92 - $68.98 $14,800 - $17,038
247 Added 2.61%
9,703 $614,000
Q4 2017

Jan 29, 2018

SELL
$59.94 - $65.35 $1,258 - $1,372
-21 Reduced 0.22%
9,456 $579,000
Q3 2017

Oct 19, 2017

BUY
$55.23 - $63.74 $523,414 - $604,063
9,477
9,477 $604,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Financial Advisory Service, Inc. Portfolio

Follow Financial Advisory Service, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advisory Service, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Advisory Service, Inc. with notifications on news.